CELL PROTX LIMITED
Company number SC489649 · Active · Aberdeen AB15 7FJ
CELL PROTX LIMITED is an active private limited company (company number SC489649) incorporated on 24 October 2014, registered in Aberdeen. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 October 2025, showing net assets of −£47k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 16% on the prior period (−£56k).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 24 October 2014
- Next accounts due
- 31 July 2027 — in 286 days
- Confirmation statement due
- 7 November 2026 — in 20 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 October 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | −£47k | — | — | £46k | — | — | 1 |
| 31 October 2024 | −£56k | — | — | £45k | — | — | 1 |
- Current ratio
- 0.1 — current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 43/100 (grade D)
- -15 Negative net assets — Net assets £-46,654 at 2025-10-31
- +8 Net assets growing — +16.3% vs prior period
- -8 Current liabilities exceed current assets — Current ratio 0.1
- +8 Established — Incorporated 2014-10-24 (12 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mfr Donald Mcphail — has significant influence or control · since 21 June 2023
- (persons with significant control statement) — · since 24 October 2016 · ceased 7 November 2023
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Aberdeen
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- ELASMOGEN LIMITED — Foresterhill, inc. Jan 2014
- TAURX THERAPEUTICS EUROPE LTD. — Aberdeen, inc. Mar 2016
- TAURX THERAPEUTICS MANAGEMENT LTD. — Aberdeen, inc. Mar 2016
- NODTHERA LIMITED — Aberdeen, inc. Jul 2016
- RAB MICROFLUIDICS RESEARCH AND DEVELOPMENT COMPANY LIMITED — Aberdeen, inc. Aug 2016
- SCOTIA BIOLOGICS LIMITED — Aberdeen, inc. Mar 2012
Reminders for CELL PROTX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.